1-16 of 16
Keywords: Relapse
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol 1–11.
Published Online: 28 August 2024
...; Jennifer White Introduction: Antithymocyte globulin (ATG) has been demonstrated to reduce the incidence of graft-versus-host disease (GVHD); however, it remains controversial whether these gains are offset by an increase in relapse. Methods: We conducted a retrospective historical control study consisting...
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol 1–6.
Published Online: 04 April 2024
...). Although uncommon, some patients may still experience molecular or hematologic relapse after treatment discontinuation, even after a prolonged duration of remission. Case Presentation: In this case series, we report the outcome of 3 patients with CML-CP who were treated with tyrosine kinase inhibitors...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2024) 147 (3): 352–359.
Published Online: 26 September 2023
...Soyoung Bae; Seungwon Sa; Silvia Park; Byung-Sik Cho; Hee-Je Kim The recently approved BCL2 inhibitor venetoclax (VEN) has achieved promising outcomes in new and relapsed/refractory (R/R) acute myeloid leukemia (AML). Although its use is not well established in R/R AML with extramedullary disease...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2022) 145 (4): 404–411.
Published Online: 19 January 2022
...; Shinichi Kako; Yoshinobu Kanda ycanda-tky@umin.ac.jp Acute myeloid leukemia Relapse Neutropenia Cytarabine D-index © 2022 S. Karger AG, Basel 2022 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2020) 143 (6): 559–566.
Published Online: 01 July 2020
...Yang Liu; Lei Wen; Huan Chen; Yao Chen; Wenbing Duan; Ying Kang; Ling Ma; Xiaojun Huang; Jin Lu Background: Serum lactate dehydrogenase (LDH) is an adverse prognostic factor for newly diagnosed multiple myeloma (MM). However, the role of LDH in the prognosis of MM patients with relapse has not yet...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (1978) 59 (4): 205–214.
Published Online: 03 March 2009
... cells occurred, a further cycle with a scarcely myelotoxic drug, L-asparaginase, was administered: a 10/13 (76.9%) remission of the disease was then achieved. This therapeutic trial was well accepted and could be more extensively used in the patients in relapse. A remission lasting between 4 and 28...
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (1984) 72 (3): 181–189.
Published Online: 25 February 2009
...P.H.G. Hogeman; A.J.P. Veerman; D.R. Huismans; C. Van Zantwijk; P.D. Bezemer; I.H. Stamhuis; F.C. De Waal In 53 children with acute lymphoblastic leukaemia (ALL), initial handmirror cell (HMC) count among lymphoblasts was studied in relation to the occurrence of a relapse in the central nervous...
Journal Articles
Journal Articles
Subject Area:
Hematology , Oncology
Acta Haematol (2000) 103 (1): 55–62.
Published Online: 13 March 2000
...Romaine Viollier; André Tichelli In a previous study, we evaluated efficacy of repeated antilymphocyte globulin (ALG) treatment for patients with severe aplastic anemia not responding to an initial ALG treatment or relapsing after initial response to ALG. We now searched in the same cohort...